title: Chemical process evolution of efavirenz, a potent non-nucleosidal HIV reverse transcriptase inhibitor.
authors.affiliation: Department of Process Research, Merck Research Laboratories, Rahway, NJ 07065, USA. cheng_chen@merck.com
authors.forename: C Y
authors.initials: CY
authors.lastname: Chen
authors.forename: L
authors.initials: L
authors.lastname: Tan
mesh_terms: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D006678:HIV / Q000201:enzymology; D008958:Models, Molecular; D015394:Molecular Structure; D010078:Oxazines / Q000138:chemical synthesis* / Q000737:chemistry*; D018894:Reverse Transcriptase Inhibitors / Q000138:chemical synthesis / Q000737:chemistry*; D013237:Stereoisomerism
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz